Pelthos Therapeutics (PTHS) Non-Current Deferred Tax Liability (2025)
Pelthos Therapeutics has reported Non-Current Deferred Tax Liability over the past 1 years, most recently at $12.9 million for Q3 2025.
Pelthos Therapeutics has reported Non-Current Deferred Tax Liability over the past 1 years, most recently at $12.9 million for Q3 2025.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month